Therefore, the long-term effects of ferroptosis on tumor immunity depend on the interactions between cancer cells and various immune and nonimmune cell subsets in the TME, and the significance of the ZNF419 gene in tumor immunity and pan-cancer immunotherapy should be considered from the perspective of ferroptosis. The gene discussed is ZNF419; the disease is cancer.